Yüklüyor......
Successful Desensitization of a Patient with Rituximab Hypersensitivity
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies. Rituximab causes hypersensitivity reactions during infusions. The delay of treatment or loss of a highly efficient drug can be prevented by rapid d...
Kaydedildi:
| Yayımlandı: | Case Reports Immunol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4320878/ https://ncbi.nlm.nih.gov/pubmed/25685566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/524507 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|